MK-677 Dosage Guide, Side Effects & Legal Status

Yes, this is one of the most common questions and combinations discussed in peptide communities. The rationale given is that injectable GHRH/GHRP peptides (CJC-1295, ipamorelin) produce a sharp, pulsatile GH release while MK-677 provides a longer, steadier elevation, so combining them is claimed to broaden the GH/IGF-1 response across the day. This combination is not studied in controlled human trials, so claims about added benefit are based on mechanism and anecdotal reports rather than clinical evidence.

MK-677 has never been approved by the FDA (or equivalent regulators elsewhere) for any human use. It is not a scheduled/controlled substance in the US, so simple possession is generally not a criminal matter, but it is sold only as a 'research use only' chemical not intended for human consumption, and marketing it for human/bodybuilding use has drawn FDA warning letters to sellers. It is also on WADA's prohibited list (category S2) for tested athletes and is flagged on the DoD's high-risk supplement list, so competitive athletes and military personnel should assume it is banned for them.

Because MK-677 is a small molecule rather than a reconstituted peptide, it is generally more stable than injectable peptides and does not require refrigeration or reconstitution. Vendors typically supply it as a stable powder or pre-dosed liquid/capsule; common guidance is to store it in a cool, dry place away from direct light and moisture, and to follow the specific supplier's stated stability and expiration information, since formulations vary.

This is a frequently raised concern because ghrelin-receptor activity and increased GH/IGF-1 can theoretically influence DHT sensitivity, and some users report increased shedding, though there is no strong clinical evidence establishing MK-677 as a direct cause of hair loss. Some studies and user reports note mild increases in cortisol and prolactin with GH secretagogue use; the clinical significance of these changes in healthy adults is not well established. As with other effects, findings are drawn from limited trials and self-reported experience rather than robust human safety data.